Mechanisms of SARS-CoV-2 entry into cells
2021/10/05 by Cody B. Jackson, Michael Farzan, Bing Chen +1 · 31 citations
Agricultural and Biological Sciences · Medicine · #Animal Virus Infections Studies #COVID-19 Clinical Research Studies #SARS-CoV-2 and COVID-19 Research
paper · pdf · doi:10.1038/s41580-021-00418-x
crossref issued 2021/10/05 · crossref published 2021/10/05 · crossref published-online 2021/10/05 · openalex publication_date 2021/10/05 · crossref created 2021/10/05 · crossref deposited 2021/12/20 · crossref published-print 2022/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29 · crossref indexed 2026/07/30
Citations
Cited by
- TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions
- SARS-CoV-2: The Interplay Between Evolution and Host Immunity
- COVID-19 disease and autoimmune disorders: A mutual pathway
- Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infection
- RECUR: identifying recurrent amino acid substitutions from multiple sequence alignments
- Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammation
- Structural Immunology of SARS‐CoV‐2
- Localizing the Glycan Binding Sites of SARS-CoV-2 Receptor-Binding Domain
- Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
- Adhesion-driven vesicle translocation through membrane-covered pores
- ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023
- Neutralizing nanobodies against SARS-CoV-2 recognizing highly conserved epitopes at the Spike’s S2 subunit
- Does COVID‐19 cause or worsen LUT dysfunction, what are the mechanisms and possible treatments? ICI‐RS 2023
- The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
- Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter study
- Long-term effects of SARS-CoV-2 infection on human brain and memory
- SARS‐CoV‐2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral release
- Organoids in respiratory virus research: advances and perspectives
- SARS‐CoV‐2 Spike Protein as a Target of the COVID‐19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes
- Next-Generation Vaccines against COVID-19 Variants: Beyond the Spike Protein
- Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis
- SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management
- Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine
- Binding ability of Delta and Omicron towards the angiotensin-converting enzyme 2 receptor and antibodies: a computational study
- Coronaviruses: Pandemic SARS-CoV-2
- Stringent selection drives convergence toward omicron-like SARS-CoV-2 receptor-binding motifs
- Therapeutic BCG vaccine protects against long COVID: The BATTLE randomized clinical trial
- Uncovering a unique pathogenic mechanism of SARS-CoV-2 omicron variant: selective induction of cellular senescence
- An antibody from single human V H -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion
- Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
- Functional and structural characterization of the SARS-CoV-2 spike N481K mutation
- Ethanol exposure suppresses Microglia pro-inflammatory response induced by SARS-CoV2-Spike protein